Over-the-counter medicines include the broad family of TYLENOL ® acetaminophen products SUDAFED ® cold, flu and allergy products BENADRYL ® and ZYRTEC ® allergy products MOTRIN ® IB ibuprofen products and the PEPCID ® line of acid reflux products. Major brands in Beauty include the AVEENO ® CLEAN & CLEAR ® DABAO ™ JOHNSON’S ® Adult LE PETITE MARSEILLAIS ® NEUTROGENA ® and OGX ® product lines. Oral Care includes the LISTERINE ® product line.
Baby Care includes the JOHNSON’S ® line of products. The Consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health and wound care markets. Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other words of similar meaning in conjunction with, among other things: discussions of future operations expected operating results and financial performance impact of planned acquisitions and dispositions the Company’s strategy for growth product development regulatory approvals market position and expenditures.
Forward-looking statements do not relate strictly to historical or current facts and reflect management’s assumptions, views, plans, objectives and projections about the future. Private Securities Litigation Reform Act of 1995. Management and representatives of Johnson & Johnson and its subsidiaries (the "Company") also may from time to time make forward-looking statements. This Annual Report on Form 10-K and Johnson & Johnson's other publicly available documents contain "forward-looking statements" within the meaning of the safe harbor provisions of the U.S.
0 kommentar(er)
